The Second Annual BIO National Venture Conference Featuring Early-Stage Private Companies
March 31 - April 1, 2009
Sheraton Boston Hotel
Boston, MA
Even in this time of economic uncertainty, the most astute investors are actively looking to the future. The second annual BIO National Venture Conference, co-hosted by the National Venture Capital Association and BIO (Biotechnology Industry Organization) is focused on new companies and breakthrough ideas.
Because BIO’s mission is to support innovation and industry-wide success, this conference offers venture capital investors unparalleled access to early-stage opportunities.
BIO’s One-on-One Partnering will also give investors, start-up companies, and business development executives the opportunity to schedule private meetings at the conference.
Don't Miss These Top-Level Speakers!
View the Presentation Schedule!
Advisory Committee
| Fred Craves, PhD | Bay City Capital |
| James Healy, MD PhD | Sofinnova Ventures |
| Stephen Hoffman, MD PhD | Skyline Ventures |
| Ronald W. Lennox, D.Phil | CHL Medical Partners |
| Scott Rocklage, PhD | 5AM Ventures |
| David Schnell, MD | Prospect Venture Partners |
| Michael Wasserman, PhD | H.I.G. Ventures |
Click here to read about the Advisory Committee
Participating Investors:
5AM Ventures
Abingworth
Advent Healthcare Ventures
Aisling Capital
Allied Minds
Apposite Capital
Arthur Ventures
Atlas Ventures
Axon Healthcare Partners, LLC
Bay City Capital
Bessemer Venture Partners
BIO*One Capital
BioCatalyst International, Inc.
Biogen Idec
BioVentures Investors
Boston Millenia Partners
Capital Midwest
Care Capital LLC
Cato BioVentures
CHL Medical Partners
CMEA Ventures
Connecticut Innovations, Inc.
Covidien Ventures
Delphi Ventures
Domain Associates, LLC
Eminent Venture Capital Corporation
Fidelity Biosciences
Genechem Management Inc
Hambrecht & Quist Capital Management
Hatteras Venture Partner
HealthCare Ventures
Hercules Technology Growth Capital, Inc.
HIG Ventures
Highland Capital Partners
Intersouth Partners
J&J Development Corporation
JAFCO Life Science Investment
Johnston Associates Inc.
Longitude Capital
Lousiana Fund I
Lumira Capital
Maverick Capital
MedImmune Ventures
Mediphase
MP Healthcare Venture Management
MPM Capital
MRA
Navigator Technology Ventures
Needham & Co.
Neomed Management
New Enterprise Associates
Novartis Venture Fund
Novo A/S
Novo Nordisk A/S
Orion Healthcare Equity Partners
Oxford Bioscience Partners
Pacific Horizon Ventures
Polaris Venture Partners
Prism VentureWorks
Prospect Venture Partner
PureTech Ventures
Rho Ventures
Seaflower Ventures
Seed-One Ventures, LLC
Siemens Venture Capital
Skyline Ventures
Slater Technology Fund
Sofinnova Ventures
SR One
SV Life Sciences
Takeda Research Investment
Teva Innovative Ventures
Thomas, McNerney & Partners
TPG Biotech
US Venture Partners
Ventures West Capital
Visium Asset Management
Warburg Pincus LLC
World Technology Ventures, LLC
For more information, please contact BIO NVC customer service:
Email: biopartnering@bio.org
Phone: 866.356.5155; +1.202.962.6666